|
Drug Targeting and Delivery Cluster
|
| Key word |
Life Sciences; Medicine; Bio technology
|
| Summary |
The mission of the Drug Targeting and Delivery Cluster is the beginning of a R&D platform for open innovation in the Life Sciences in the Northern Netherlands. It is a forum for sharing scientific, technological and market information, as well as business concepts and experiences covering the entire bio-medical community. It can serve as a nucleus for an expanding life science community that eventually achieves the critical mass necessary to attract larger pharmaceutical partners to invest in programs and/or establish facilities in the region. The members of the Northern Drug Targeting and Delivery Cluster, by pooling their technologies and expertises, are aiming to more effectively position themselves to take advantage of this changing dynamic by developing and marketing innovative ready-made pharmaceutical proof of concepts.
|
| Public partners |
University of Groningen
University Medical Center Groningen (UMCG)
|
| Private partners |
BioMaDe, BiOrion Technologies B.V., CELLution Biotech B.V., Innocore B.V., Nyken B.V., Synvolux Therapeutics B.V., Triskel Therapeutics B.V., ViciniVax B.V., Vivomicx
|
| Faculties involved |
Faculty of Mathematics and Natural Sciences
Faculty Medical Sciences
|
| Sponsors |
Samenwerkingsverband Noord-Nederland SNN (Provinces of Groningen, Friesland, Drenthe);European Commission
|
| Funding programmes |
Pieken in de Delta
EFRO
|
| Budget |
€
1.454.320,00
|
| Activity TLG |
Project management
|
| Contact person TLG |
Annemieke Galema
|
|
Contact person
Drug Targeting and Delivery Cluster
|
Prof. dr. Ingrid Molema, Life Sciences, University of Groningen
|
| Scientific direc-tor Drug Targe-ting and Deli-very Cluster |
Prof. dr. Ingrid Molema, Life Sciences, University of Groningen
|
| Start project |
1 January 2008 |
| Final date |
31 December 2013 |
| Brochure |
Northern Drug Targeting and Delivery Cluster [PDF]
|
| Website |
Transfer & Liaison Groep
|
|
|
